Fig. 4From: Ketoglutaric acid can reprogram the immunophenotype of triple-negative breast cancer after radiotherapy and improve the therapeutic effect of anti-PD-L1Expression of CCL5 and CXCL10 mRNA by RT‒qPCR and ELISA quantification of CCL5 and CXCL10 protein levels in the supernatants of 4T1 (A) and MDA-MB-231 (B) cells under different treatments. (C) Flow cytometry showed the activation of 4T1 cell culture medium on DCs under different treatmentsBack to article page